Detalles de la búsqueda
1.
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.
N Engl J Med
; 390(10): 875-888, 2024 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38446675
2.
Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma.
N Engl J Med
; 384(12): 1125-1135, 2021 03 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33577729
3.
Progression-free survival and safety at 3.5 years of follow-up: results from the randomized phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer - a plain language summary.
Future Oncol
; 2024 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38501262
4.
Malnutrition prevalence in cancer patients in Belgium: The ONCOCARE study.
Support Care Cancer
; 32(2): 135, 2024 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38280135
5.
Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer.
Gynecol Oncol
; 170: 300-308, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36758420
6.
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
N Engl J Med
; 381(25): 2391-2402, 2019 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31562799
7.
Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study.
Gynecol Oncol
; 166(1): 36-43, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35550709
8.
Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001.
Int J Gynecol Cancer
; 32(1): 93-100, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34799418
9.
Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer: a study of the Belgian and Luxembourg Gynaecological Oncology Group.
Int J Gynecol Cancer
; 32(6): 753-760, 2022 06 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35063943
10.
Elective nodal radiotherapy in prostate cancer.
Lancet Oncol
; 22(8): e348-e357, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34339655
11.
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.
Lancet Oncol
; 22(7): 931-945, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34051178
12.
AMTRA: a multicentered experience of a web-based monitoring and tailored toxicity management system for cancer patients.
Support Care Cancer
; 29(2): 859-867, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32519044
13.
Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer.
Breast Cancer Res Treat
; 181(1): 97-105, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32240454
14.
Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients.
Breast Cancer Res Treat
; 152(1): 67-76, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26017071
15.
Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors.
BMC Cancer
; 14: 201, 2014 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-24641830
16.
Readressing the rationale of irradiation in stage I seminoma guidelines: a critical essay.
BJU Int
; 124(1): 35-39, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30680874
17.
Health-related Quality of Life in Patients with Previously Treated Advanced Urothelial Carcinoma from EV-301: A Phase 3 Trial of Enfortumab Vedotin Versus Chemotherapy.
Eur Urol
; 2024 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38418343
18.
First Evidence of Activity of Enfortumab Vedotin on Brain Metastases in Urothelial Cancer Patients.
Pharmaceuticals (Basel)
; 16(3)2023 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36986475
19.
The Role of Abdominal Surgery in Refractory Immune Checkpoint Inhibitor Enterocolitis: A Case Report.
Case Rep Oncol
; 16(1): 438-445, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37384210
20.
Extensive CArdioVAscular Characterization and Follow-Up of Patients Receiving Immune Checkpoint Inhibitors: A Prospective Multicenter Study.
Pharmaceuticals (Basel)
; 16(4)2023 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37111382